Yu Kasamatsu Selected Research

Yu Kasamatsu Research Topics

4	COVID-19 07/2021 - 11/2020
2	Human Influenza (Influenza) 07/2021 - 11/2020
2	Pneumonia (Pneumonitis) 01/2021 - 02/2012
1	Coronavirus Infections 07/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Hemorrhage 01/2021
1	Hyperuricemia 11/2020
1	Epstein-Barr Virus Infections 08/2020
1	Bacteremia 06/2017
1	Infections 06/2017
1	Amebic Liver Abscess 01/2016
1	Multiple Myeloma 01/2016
1	Abscess 01/2016
1	Pericardial Effusion 05/2013
1	Eosinophilia 05/2013
1	Confusion (Bewilderment) 02/2012
1	Vasculitis (Vasculitides) 08/2010
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2010
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2010
1	Fibrosis (Cirrhosis) 01/2010
1	Rupture 01/2010
1	Aneurysm (Aneurysms) 01/2010

2	favipiravirIBA 07/2021 - 11/2020
2	ProcalcitoninIBA 06/2017 - 02/2012
2	Prednisolone (Predate)FDA LinkGeneric 05/2013 - 01/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2010 - 01/2010
1	Pharmaceutical PreparationsIBA 07/2021
1	Antiviral Agents (Antivirals)IBA 07/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Viral RNAIBA 11/2020
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 08/2020
1	C-Reactive ProteinIBA 06/2017
1	Indicators and Reagents (Reagents)IBA 06/2017
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	Urea (Carbamide)FDA LinkGeneric 02/2012
1	Antiphospholipid AntibodiesIBA 08/2010
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 08/2010